Northwest & Ethical Investments L.P. grew its stake in shares of Relx Plc (NYSE:RELX – Free Report) by 5.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 210,600 shares of the technology company’s stock after purchasing an additional 11,139 shares during the quarter. Northwest & Ethical Investments L.P.’s holdings in Relx were worth $9,565,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. CENTRAL TRUST Co boosted its holdings in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after acquiring an additional 529 shares during the period. Versant Capital Management Inc bought a new stake in Relx in the fourth quarter valued at approximately $31,000. Sierra Ocean LLC purchased a new stake in shares of Relx during the fourth quarter valued at approximately $43,000. Private Trust Co. NA grew its holdings in shares of Relx by 119.9% in the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after purchasing an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC purchased a new position in shares of Relx in the fourth quarter worth $74,000. Hedge funds and other institutional investors own 15.02% of the company’s stock.
Relx Stock Performance
Shares of RELX stock opened at $49.94 on Friday. The firm has a market capitalization of $92.70 billion, a price-to-earnings ratio of 26.85, a PEG ratio of 2.73 and a beta of 0.90. The stock has a fifty day moving average of $49.11 and a 200 day moving average of $47.67. Relx Plc has a 52 week low of $40.25 and a 52 week high of $51.99. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.
Relx Increases Dividend
Wall Street Analysts Forecast Growth
RELX has been the subject of several analyst reports. Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Finally, Redburn Atlantic initiated coverage on Relx in a research note on Wednesday, January 8th. They issued a “buy” rating on the stock.
Read Our Latest Report on Relx
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- What is the S&P/TSX Index?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- 3 Fintech Stocks With Good 2021 Prospects
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- The 3 Best Retail Stocks to Shop for in August
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.